Clintrax Global company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired

About Clintrax Global

Clintrax Global specializes in global clinical trial contract negotiation and investigator payments. The company acts as a functional service provider for pharmaceutical/biotechnology companies and CROs during the process of drug development. Clintrax provides these clients with worldwide contract negotiation and payments services to clinical trial sites including small clinics, large hospitals, and multicenter academic insititutions.

Clintrax Global Headquarter Location

4600 Marriott Drive Suite 20

Raleigh, North Carolina, 27612,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Clintrax Global News

Fierce Innovation Awards Healthcare Edition Recognizes Pulsara as Finalist

Oct 3, 2016

Clintrax Global named finalist for 2016 Life Sciences Awards Pulsara announced today that they have been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition 2016, an awards program from the publisher of FierceHealthcare, FierceHealthIT, and FierceHealthPayer. Pulsara was recognized as a finalist in the category of Digital/Mobile Health Solutions. Pulsara was selected as a finalist for their innovative, industry leading product, the Pulsara platform, which currently includes STEMI and stroke modules, with sepsis and trauma in the works. Finalists were selected by a distinguished panel of CIOs from renowned U.S. hospitals and healthcare systems, including Aspirus, Cook Children’s Health Care System, and JFK Health System, among others. A complete list of judges can be found at . All applications were evaluated based on the following criteria: care efficiency, competitive advantage, financial impact/value, market need, patient experience/satisfaction, quality of care and patient outcomes, and overall fierceness and innovation. Finalists were selected based on calculation of the judges’ scores in each area. "Pulsara is humbled and excited to have been nominated for this prestigious award by leading CIOs across this nation. This speaks to our mission of simplifying communications," said Dr. James Woodson, Founder, and CEO of Pulsara. "Together we are changing the face of healthcare in the name of better performance outcomes, and we are honored to be at the forefront of the movement. " Pulsara is currently implemented in 9 states and Australia and demonstrates a 10-46% reduction in treatment times for STEMI and stroke patients. EMS agencies and hospitals are able to reduce risks during transitions of care, improve turnaround times for EMS, improve capture of registration and billing information, eliminate costs for ECG transmission, reduce costly false activations, and reduce length of stay. Hospitals have demonstrated a yearly 10X ROI using the platform. To learn more about Pulsara visit, . ### About FierceMarkets FierceMarkets, a division of Questex, LLC, is a leader in B2B e-media, providing information and marketing services in the telecommunications, life sciences, healthcare and technology industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets' wide array of digital publications reaches more than 2 million executives in more than 100 countries. Current publications include: Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe /TelecomsEMEA, FierceInstaller; Healthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceHealthPayerAntiFraud; FierceMobileHealthcare; FiercePracticeManagement and Hospital Impact; Life Sciences: FierceAnimalHealth; FierceBiotech; FierceBiotechIT; FierceBiotechResearch; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaAsia; FiercePharmaMarketing; FiercePharmaManufacturing; and FierceVaccines; Technology: FierceTechExec. About Pulsara Pulsara is a digital healthcare corporation that focuses on using mobile technology to enhance treatment time outcomes by improving communication and care coordination through the entire healthcare system. Pulsara’s mobile applications STOP STROKE and STOP STEMI improve communications between the teams caring for stroke and heart attack patients, leading to faster treatment and better outcomes. Every clinician – from paramedics to emergency department staff to neurology and cardiology teams – is on the same page with a simple tap. For more information, visit . For the original version on PRWeb visit:

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.